On the efficacy of malaria DNA vaccination with magnetic gene vectors

Journal of Controlled Release

Volumn 168, Issue 1, 2013, Pages 10-17

  Nawwab Al Deen, Fatin ^a   Ma, Charles ^a   Xiang, Sue D ^b   Selomulya, Cordelia ^a   Plebanski, Magdalena ^b   Coppel, Ross L ^a  

^a MONASH UNIVERSITY   (Australia)

^b MONASH UNIVERSITY   (Australia)

Author keywords

Administration routes; Antibody response; In vivo; Malaria DNA vaccine; SPIONs

Indexed keywords

ANTIBODY RESPONSE; DNA VACCINE; IN-VIVO; INTRADERMAL INJECTION; INTRAMUSCULAR INJECTIONS; INTRAPERITONEAL ADMINISTRATION; SERUM ANTIBODY TITERS; SPIONS;

ANTIBODIES; DISEASES; IMMUNE SYSTEM; SUPERPARAMAGNETISM; WATER INJECTION;

VACCINES;

DNA VACCINE; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2A; IMMUNOGLOBULIN G2B; PLASMID DNA; POLYETHYLENEIMINE; SUPERPARAMAGNETIC IRON OXIDE NANOPARTICLE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY BLOOD LEVEL; ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; DENDRITIC CELL; DNA IMMUNIZATION; DRUG ADMINISTRATION ROUTE; DRUG DELIVERY SYSTEM; DRUG DESIGN; DRUG EFFICACY; DRUG FORMULATION; FEMALE; GENE; GENE VECTOR; IMMUNE RESPONSE; IMMUNITY; IN VIVO STUDY; MACROPHAGE; MAGNETIC GENE VECTOR; MALARIA; MALARIA DNA VACCINATION; MOUSE; NONHUMAN; OUTCOME ASSESSMENT; PERITONEUM; PRIORITY JOURNAL; VR1020 PYMSP119 GENE;

ANIMALS; ANTIBODIES, PROTOZOAN; DNA; FEMALE; FERRIC COMPOUNDS; GENETIC VECTORS; IMMUNOGLOBULIN G; MAGNETIC PHENOMENA; MALARIA VACCINES; MICE; MICE, INBRED BALB C; NANOPARTICLES; POLYETHYLENEIMINE; VACCINES, DNA;

EID: 84875293396     PISSN: 01683659     EISSN: 18734995     Source Type: Journal    
DOI: 10.1016/j.jconrel.2013.02.030     Document Type: Article

References (55)

1. M.A. Liu DNA vaccines: an historical perspective and view to the future Immunol. Rev. 239 2011 62 84
2. C.L. Diggs, W.R. Ballou, and L.H. Miller The major merozoite surface protein as a malaria vaccine target Parasitol. Today 9 1993 300 302
3. A.N. Hodder, P.E. Crewther, M. Matthew, G.E. Reid, R.L. Moritz, R.J. Simpson, and R.F. Anders The disulfide bond structure of Plasmodium apical membrane antigen-1 J. Biol. Chem. 271 1996 29446 29452
4. T.M. Daly, and C.A. Long Humoral response to a carboxyl-terminal region of the merozoite surface protein-1 plays a predominant role in controlling blood-stage infection in rodent malaria J. Immunol. 155 1995 236 243
5. S. Kumar, A. Yadava, D.B. Keister, J.H. Tian, M. Ohl, K.A. Perduegreenfield, L.H. Miller, and D.C. Kaslow Immunogenicity and in-vivo efficacy of recombinant Plasmodium falciparum merozoite surface protein-1 in Aotus monkeys Mol. Med. 1 1995 325 332
6. R.A. O'Donnell, T.F. de Koning-Ward, R.A. Burt, M. Bockarie, J.C. Reeder, A.F. Cowman, and B.S. Crabb Antibodies against merozoite surface protein (MSP)-1(19) are a major component of the invasion-inhibitory response in individuals immune to malaria J. Exp. Med. 193 2001 1403 1412
7. V. Vijayanathan, T. Thomas, and T.J. Thomas DNA nanoparticles and development of DNA delivery vehicles for gene therapy Biochemistry 41 2002 14085 14094
8. F. Krotz, H.Y. Sohn, T. Gloe, C. Plank, and U. Pohl Magnetofection potentiates gene delivery to cultured endothelial cells J. Vasc. Res. 40 2003 425 434
9. F.N. Al-Deen, C. Selomulya, and T. Williams On designing stable magnetic vectors as carriers for malaria DNA vaccine Colloids Surf. B Biointerfaces 102 2013 492 503
10. F.N. Al-Deen, J. Ho, C. Selomulya, C. Ma, and R. Coppel Superparamagnetic nanoparticles for effective delivery of malaria DNA vaccine Langmuir 27 2011 3703 3712
11. S. Parween, P.K. Gupta, and V.S. Chauhan Induction of humoral immune response against PfMSP-119 and PvMSP-119 using gold nanoparticles along with alum Vaccine 29 2011 2451 2460
12. D. Mohanan, B. Slutter, M. Henriksen-Lacey, W. Jiskoot, J.A. Bouwstra, Y. Perrie, T.M. Kundig, B. Gander, and P. Johansen Administration routes affect the quality of immune responses: a cross-sectional evaluation of particulate antigen-delivery systems J. Control. Release 147 2010 342 349
13. G.T. Brice, C. Dobano, M. Sedegah, M. Stefaniak, N.L. Graber, J.J. Campo, D.J. Carucci, and D.L. Doolan Extended immunization intervals enhance the immunogenicity and protective efficacy of plasmid DNA vaccines Microbes Infect. 9 2007 1439 1446
14. R.R. Deck, C.M. DeWitt, J.J. Donnelly, M.A. Liu, and J.B. Ulmer Characterization of humoral immune responses induced by an influenza hemagglutinin DNA vaccine Vaccine 15 1997 71 78
15. S. Liu, M.K. Danquah, G.M. Forde, C. Ma, L. Wang, and R. Coppel Microparticle-mediated gene delivery for the enhanced expression of a 19-KDa fragment of merozoite surface protein 1 of Plasmodium falciparum Biotechnol. Prog. 26 2010 257 262
16. M.S. Cherif, M.N. Shuaibu, T. Kurosaki, G.K. Helegbe, M. Kikuchi, T. Yanagi, T. Tsuboi, H. Sasaki, and K. Hirayama Immunogenicity of novel nanoparticle-coated MSP-1 C-terminus malaria DNA vaccine using different routes of administration Vaccine 29 2011 9038 9050
17. E.L. Johansson, C. Bergquist, A. Edebo, C. Johansson, and A.M. Svennerholm Comparison of different routes of vaccination for eliciting antibody responses in the human stomach Vaccine 22 2004 984 990
18. D.L. Lodmell, N.B. Ray, J.T. Ulrich, and L.C. Ewalt DNA vaccination of mice against rabies virus: effects of the route of vaccination and the adjuvant monophosphoryl lipid A (MPL (R)) Vaccine 18 2000 1059 1066
19. L. Xiang, W. Bin, J. Huali, J. Wei, T. Jiesheng, G. Feng, and L. Ying Bacterial magnetic particles (BMPs)-PEI as a novel and efficient non-viral gene delivery system J. Gene Med. 9 2007 679 690
20. V. Manolova, A. Flace, M. Bauer, K. Schwarz, P. Saudan, and M.F. Bachmann Nanoparticles target distinct dendritic cell populations according to their size Eur. J. Immunol. 38 2008 1404 1413
21. P. Chollet, M.C. Favrot, A. Hurbin, and J.L. Coll Side-effects of a systemic injection of linear polyethylenimine-DNA complexes J. Gene Med. 4 2002 84 91
22. X.F. Zhou, B. Liu, X.H. Yu, X. Zha, X.Z. Zhang, X.Y. Wang, Y.H. Jin, Y.G. Wu, C.L. Jiang, Y. Chen, Y.M. Shan, J.Q. Liu, W. Kong, and J.C. Shen Using magnetic force to enhance immune response to DNA vaccine Small 3 2007 1707 1713
23. M. Ogris, S. Brunner, S. Schuller, R. Kircheis, and E. Wagner PEGylated DNA/transferrin-PEI complexes: reduced interaction with blood components, extended circulation in blood and potential for systemic gene delivery Gene Ther. 6 1999 595 605
24. L. Wightman, R. Kircheis, V. Rossler, S. Carotta, R. Ruzicka, M. Kursa, and E. Wagner Different behavior of branched and linear polyethylenimine for gene delivery in vitro and in vivo J. Gene Med. 3 2001 362 372
25. A.K. Gupta, and M. Gupta Synthesis and surface engineering of iron oxide nanoparticles for biomedical applications Biomaterials 26 2005 3995 4021
26. J. Intra, and A.K. Salem Characterization of the transgene expression generated by branched and linear polyethylenimine-plasmid DNA nanoparticles in vitro and after intraperitoneal injection in vivo J. Control. Release 130 2008 129 138
27. Y. Hattori, S. Kawakami, K. Nakamura, F. Yamashita, and M. Hashida Efficient gene transfer into macrophages and dendritic cells by in vivo gene delivery with mannosylated lipoplex via the intraperitoneal route J. Pharmacol. Exp. Ther. 318 2006 828 834
28. K.E. Weck, S.S. Kim, H.W. Virgin, and S.H. Speck Macrophages are the major reservoir of latent murine gammaherpesvirus 68 in peritoneal cells J. Virol. 73 1999 3273 3283
29. R. Rezzani, L. Rodella, G. Zauli, L. Caimi, and M. Vitale Mouse peritoneal cells as a reservoir of late dendritic cell progenitors Br. J. Haematol. 104 1999 111 118
30. S.W.K. Chapman, P.O. Hassa, S. Koch-Schneidemann, B. von Rechenberg, M. Hofmann-Amtenbrink, B. Steitz, A. Petri-Fink, H. Hofmann, and M.O. Hottiger Application of pulsed-magnetic field enhances non-viral gene delivery in primary cells from different origins J. Magn. Magn. Mater. 320 2008 1517 1527
31. G.F. Goya, I. Marcos-Campos, R. Fernandez-Pacheco, B. Saez, J. Godino, L. Asin, J. Lambea, P. Tabuenca, J.I. Mayordomo, L. Larrad, M.R. Ibarra, and A. Tres Dendritic cell uptake of iron-based magnetic nanoparticles Cell Biol. Int. 32 2008 1001 1005
32. M.H.A. Guedes, N. Sadeghiani, D.L.G. Peixoto, J.P. Coelho, L.S. Barbosa, R.B. Azevedo, S. Kuckelhaus, M.D. Da Silva, P.C. Morais, and Z.G.M. Lacava Effects of AC magnetic field and carboxymethyldextran-coated magnetite nanoparticles on mice peritoneal cells J. Magn. Magn. Mater. 293 2005 283 286
33. 4-nanoparticles acute toxicity in mice Biomed. Eng. Appl. Basis Commun. 24 2012 229 235
34. J.S. Kim, T.J. Yoon, B.G. Kim, S.J. Park, H.W. Kim, K.H. Lee, S.B. Park, J.K. Lee, and M.H. Cho Toxicity and tissue distribution of magnetic nanoparticles in mice Toxicol. Sci. 89 2006 338 347
35. A. Nacev, C. Beni, O. Bruno, and B. Shapiro Magnetic nanoparticle transport within flowing blood and into surrounding tissue Nanomedicine 5 2010 1459 1466
36. K. Aoki, S. Furuhata, K. Hatanaka, M. Maeda, J.S. Remy, J.P. Behr, M. Terada, and T. Yoshida Polyethylenimine-mediated gene transfer into pancreatic tumor dissemination in the murine peritoneal cavity Gene Ther. 8 2001 508 514
37. A. Aigner, D. Fischer, T. Merdan, C. Brus, T. Kissel, and F. Czubayko Delivery of unmodified bioactive ribozymes by an RNA-stabilizing polyethylenimine (LMW-PEI) efficiently down-regulates gene expression Gene Ther. 9 2002 1700 1707
38. R.S. Chu, O.S. Targoni, A.M. Krieg, P.V. Lehmann, and C.V. Harding CpG oligodeoxynucleotides act as adjuvants that switch on T helper 1 (Th1) immunity FASEB J. 12 1998 A612-A612
39. T.M. Pertmer, T.R. Roberts, and J.R. Haynes Influenza virus nucleoprotein-specific immunoglobulin G subclass and cytokine responses elicited by DNA vaccination are dependent on the route of vector DNA delivery J. Virol. 70 1996 6119 6125
40. D.M. Feltquate, S. Heaney, R.G. Webster, and H.L. Robinson Different T helper cell types and antibody isotypes generated by saline and gene gun DNA immunization J. Immunol. 158 1997 2278 2284
41. W.I. White, C.B. Evans, and D.W. Taylor Antimalarial antibodies of the immunoglobulin g2a isotype modulate parasitemias in mice infected with Plasmodium yoelii Infect. Immun. 59 1991 3547 3554
42. I.T. Ling, S.A. Ogun, P. Momin, R.L. Richards, N. Garcon, J. Cohen, W.R. Ballou, and A.A. Holder Immunization against the murine malaria parasite Plasmodium yoelii using a recombinant protein with adjuvants developed for clinical use Vaccine 15 1997 1562 1567
43. H. Bouharountayoun, and P. Druilhe Plasmodium falciparum malaria - evidence for an isotype imbalance which may be responsible for delayed acquisition of protective immunity Infect. Immun. 60 1992 1473 1481
44. S.-Y. Lim Phytol-based novel adjuvants in vaccine formulation: 2. assessment of efficacy in the induction of protective immune responses to lethal bacterial infections in mice J. Immune Based Ther. Vaccines 4 2006 5
45. A.M. Carcaboso, R.M. Hernandez, M. Igartua, J.E. Rosas, M.E. Patarroyo, and J.L. Pedraz Potent, long lasting systemic antibody levels and mixed Th1/Th2 immune response after nasal immunization with malaria antigen loaded PLGA microparticles Vaccine 22 2004 1423 1432
46. R.L. Coffman, B.W.P. Seymour, D.A. Lebman, D.D. Hiraki, J.A. Christiansen, B. Shrader, H.M. Cherwinski, H.F.J. Savelkoul, F.D. Finkelman, M.W. Bond, and T.R. Mosmann The role of helper T-cell products in mouse B-cell differentiation and isotype regulation Immunol. Rev. 102 1988 5 28
47. J.I. Sin, M. Bagarazzi, C. Pachuk, and D.B. Weiner DNA priming-protein boosting enhances both antigen-specific antibody and Th1-type cellular immune responses in a murine herpes simplex virus-2 gD vaccine model DNA Cell Biol. 18 1999 771 779
48. C. Hirunpetcharat, J.H. Tian, D.C. Kaslow, N. vanRooijen, S. Kumar, J.A. Berzofsky, L.H. Miller, and M.F. Good Complete protective immunity induced in mice by immunization with the 19-kilodalton carboxyl-terminal fragment of the merozoite surface protein-1 (MSP1(19)) of Plasmodium yoelii expressed in Saccharomyces cerevisiae - Correlation of protection with antigen-specific antibody titer, but not with effector CD4(+) T cells J. Immunol. 159 1997 3400 3411
49. M. Plebanski, and A.V.S. Hill The immunology of malaria infection Curr. Opin. Immunol. 12 2000 437 441
50. I.A. Ramshaw, and A.J. Ramsay The prime-boost strategy: exciting prospects for improved vaccination Immunol. Today 21 2000 163 165
51. A.V.S. Hill, A. Reyes-Sandoval, G. O'Hara, K. Ewer, A. Lawrie, A. Goodman, A. Nicosia, A. Folgori, S. Colloca, R. Cortese, S.C. Gilbert, and S.J. Draper Prime-boost vectored malaria vaccines progress and prospects Hum. Vaccin. 6 2010 78 83
52. C. Ma, L.N. Wang, D.E. Webster, A.E. Campbell, and R.L. Coppel Production, characterisation and immunogenicity of a plant-made Plasmodium antigen-the 19 kDa C-terminal fragment of Plasmodium yoelii merozoite surface protein 1 Appl. Microbiol. Biotechnol. 94 2012 151 161
53. H. Kasuya, S. Nomoto, and A. Nakao The potential of gene therapy in the treatment of pancreatic cancer Drugs Today 38 2002 457 464
54. D.G. Jayne The molecular biology of peritoneal carcinomatosis from gastrointestinal cancer Ann. Acad. Med. Singapore 32 2003 219 225
55. M.H. Louis, S. Dutoit, Y. Denoux, P. Erbacher, E. Deslandes, J.P. Behr, P. Gauduchon, and L. Poulain Intraperitoneal linear polyethylenimine (L-PEI)-mediated gene delivery to ovarian carcinoma nodes in mice Cancer Gene Ther. 13 2006 367 374